Skip to main content

Table 2 Consumption of typical antipsychotics covered by Israel’s national health care system, 2004 – 2013 (defined daily dose per 1000 psychiatric inpatients per day)

From: Trends in the use of antipsychotics in the Israeli inpatient population, 2004–2013

 

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

Perphenazine

1.39

1.55

2.04

2.23

2.39

2.38

1.90

2.57

2.64

2.55

Thioridazine

0.42

0.44

0.27

0.32

0.32

0.31

0.28

0.16

0.15

0.18

Clothiapine

6.37

5.27

8.37

5.83

6.59

5.58

6.66

6.64

5.37

4.63

Levomepromazine

0.77

0.95

0.84

0.7

1.19

0.61

0.82

0.77

0.79

1.05

Fluphenazine

70.25

61.17

58.92

57.69

56.86

58.00

54.74

65.53

56.78

57.56

Propericiazine(Periciazine)

0.12

0.14

0.12

0.18

0.22

0.16

0.15

0.13

0.18

0.17

Chlorpromazine

4.00

4.41

3.90

3.31

4.02

3.65

3.69

3.40

3.05

1.52

Haloperidol

42.37

42.31

37.64

45.34

45.75

47.32

45.83

49.04

40.63

38.95

Flupentixol

0.45

0.32

0.25

0.26

0.28

0.18

1.76

0.29

0.11

0.15

Zuclopenthixol

21.05

14.26

16.26

18.79

18.83

19.09

17.59

19.21

17.94

17.58

Pimozide

0.03

0.01

0.07

0.15

0.13

0.12

0.12

0.12

0.01

0.24

Sulpiride

1.40

1.56

2.59

1.58

1.53

1.59

1.10

1.03

1.16

0.99

Total

148.62

132.39

131.27

136.38

138.11

138.99

134.64

148.89

128.81

125.57